Could a drug already approved for some cancers help patients with rare genetic tumor types?
Disease control
Recruiting now
This study tests atezolizumab, a drug already approved for certain cancers, in adults and children with rare cancers that have high tumor mutational burden (TMB) or microsatellite instability (MSI). About 30 participants will receive the drug to see if it shrinks tumors or stops …
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Apr 28, 2026 13:01 UTC